Menstural Blood: A Medium Full of Information for Reproductive Diseases


Menstural Blood: A Medium Full of Information for Reproductive Diseases

Menstrual blood could be a valuable tool to better understand the pathophysiology of reproductive diseases like endometriosis.

Key Points

Highlights: 

  • Menstrual blood harbors a distinct, tissue-adapted immune landscape differing fundamentally from peripheral blood.
  • Disease-specific immune and metabolic patterns are observed in endometriosis and PCOS.

Importance: 

  • Menstrual blood represents a non-invasive, biologically relevant window into endometrial immune status.
  • Enables immune profiling of reproductive diseases without invasive tissue sampling, supporting biomarker discovery and disease stratification.

What’s done here:

  • This is an exploratory cross-sectional study of matched peripheral and menstrual blood from 23 women.
  • 27-color flow cytometry performed in healthy controls (n=5), endometriosis (n=5), and PCOS (n=4).
  • The immune cell profiles of mononuclear cells from the menstrual and peripheral blood were compared.

Key results:

  • Menstrual mononuclear cells exhibit a distinct immune composition compared to Peripheral mononuclear cells: enriched in tissue-resident NK cells, macrophages, and dendritic cells.
  • T cells in menstrual blood show increased mitochondrial mass, indicating a metabolically active, tissue-adapted phenotype.
  • Immune checkpoint expression (e.g., PD-1) is elevated in specific T-cell subsets, suggesting activation/exhaustion dynamics.
  • Endometriosis and PCOS demonstrate divergent, disease-specific immune signatures, rather than a uniform “reproductive disease” pattern.
  • Distinct immune cell populations (e.g., dendritic cell subsets) may differentiate disease states.

Strengths and Limitations:

  • Strengths are : first integration of immune and metabolic profiling in menstrual blood; high-dimensional, multi-parametric analysis capturing broad immune heterogeneity; direct comparison with matched peripheral blood.
  • Limitations are: small exploratory cohort (n=4–5 per group); self-reported diagnosis without staging or hormonal context; lack of multiple comparison correction; findings are hypothesis-generating; mitochondrial mass used as a surrogate, not functional metabolic assessment. 

From the Editor-in-Chief – EndoNews

"This study positions menstrual blood as a biologically relevant compartment rather than a surrogate of peripheral immunity. The clear divergence between menstrual and peripheral blood immune profiles—particularly the enrichment of tissue-resident populations and the distinct metabolic signatures—supports the concept that menstrual fluid reflects the local immune environment of the reproductive tract with greater fidelity.

The integration of high-dimensional immunophenotyping with mitochondrial profiling adds an important mechanistic layer, linking immune cell composition to metabolic state. The observation that endometriosis and PCOS exhibit divergent, rather than convergent, immune patterns further challenges the tendency to group reproductive disorders under a single inflammatory framework and instead supports disease-specific immunobiology.

At the same time, the exploratory nature of the study, including small cohort size and reliance on self-reported diagnoses, appropriately limits the immediate translational application of these findings. The absence of longitudinal data and clinical stratification also highlights the need for validation in well-characterized cohorts.

Nonetheless, the study establishes a methodological and conceptual foundation for accessing endometrial immunity through a non-invasive medium. Future progress will depend on integrating such approaches within personalized, multimodal, and multidisciplinary frameworks, where immune profiling is interpreted alongside clinical, imaging, and molecular data.

Menstrual blood may not replace tissue—but it has the potential to redefine how we access it."

Lay Summary

A study published in ImmunoHorizons by Dr. April Rees and colleagues from Swansea University Medical School, UK, demonstrates that menstrual blood provides a biologically informative and non-invasive window into immune processes underlying reproductive diseases.

Using an optimized high-dimensional,27-color flow cytometry platform incorporating mitochondrial profiling, the authors analyzed menstrual and matched peripheral blood mononuclear cells from healthy individuals and patients with endometriosis or polycystic ovary syndrome (PCOS).

This approach enabled detailed characterization of 40 immune cell subsets across 546 immunological parameters, including activation, migration, exhaustion, and metabolic features.

Menstrual blood exhibited a distinct immune landscape compared to peripheral blood, enriched in tissue-resident natural killer cells, macrophages, and dendritic cells, and characterized by increased mitochondrial mass in T-cell populations, consistent with a metabolically active, tissue-adapted immune environment.

Importantly, disease-specific immune signatures were observed. Endometriosis and PCOS displayed divergent patterns across multiple immune cell subsets, including regulatory T cells, CD4 central memory cells, plasmablasts, and dendritic cells, indicating that these conditions do not share a uniform immunological phenotype.

These findings position menstrual blood as a clinically accessible source for high-resolution immune profiling and support its potential role in biomarker discovery and disease stratification in reproductive medicine.


Research Source: https://pubmed.ncbi.nlm.nih.gov/41885004/


polycystic ovary syndrome menstrual blood biomarker

DISCLAIMER

EndoNews highlights the latest peer-reviewed scientific research and medical literature that focuses on endometriosis. We are unbiased in our summaries of recently-published endometriosis research. EndoNews does not provide medical advice or opinions on the best form of treatment. We highly stress the importance of not using EndoNews as a substitute for seeking an experienced physician.